When Michio Kurosu, PhD, returned to Memphis after completing his Fulbright appointment in Egypt, he brought home more than memories of a year abroad. As the first U.S. Fulbright Scholar to reside in Sinai, Egypt, where he served his appointment at King Salman International University (KSIU) on Egypt’s Sinai Peninsula, he helped strengthen a developing pharmacy program, establish new international research partnerships and open new opportunities for future drug discovery.
“Perhaps the greatest personal outcome of my Fulbright experience was this renewed sense of purpose,” Dr. Kurosu said.
Dr. Kurosu, a professor in the University of Tennessee Health Sciences College of Pharmacy, was the first faculty member from the college to serve in the Fulbright program, whose appointment lasted from November 2025 to August 2026.
KSIU, a young institution established six years ago in Egypt’s Sinai Peninsula, specifically requested Dr. Kurosu because of his expertise in pharmaceutical science and his position at the College of Pharmacy to evaluate its developing pharmacy program.
“Working in a different academic and cultural environment gave me an opportunity not only to contribute my knowledge and experience, but also to reflect on the educational and research environment that we often take for granted in the United States,” Dr. Kurosu said.
For Dr. Kurosu, the experience reflected the Fulbright program’s mission of fostering international understanding through education and collaboration.
“The value of the program extends beyond simply visiting another country and sharing American academic expertise,” he said. “A Fulbright Scholar should also learn from the host country, its culture, educational system, scientific priorities and local challenges, and use that understanding to build meaningful and sustainable collaborations.”
Bringing UT Health Sciences Pharmacy Expertise to Sinai
Dr. Kurosu’s main duties at the college included teaching courses to students at the university as well as meeting with faculty and students to evaluate and present a comprehensive review of KSIU’s pharmacy program. During the appointment, he evaluated curriculum design, course content, teaching materials, student performance and educational outcomes, drawing on established practices, experience and the success of the UT Health Sciences College of Pharmacy. He also provided recommendations to improve the integration of pharmaceutical sciences and clinical education, supporting the development of the university.
“As a well-established U.S. college of pharmacy with a strong reputation in pharmacy education, biomedical and pharmaceutical research, and clinical training, UT Health Sciences provided a valuable benchmark for assessing the KSIU program,” Dr. Kurosu said.
For Dr. Kurosu, the experience highlighted the global influence of pharmacy education and the role institutions like UT Health Sciences can play in shaping future generations of healthcare professionals worldwide.
New Partnerships Create New Opportunities for Discovery
While Dr. Kurosu’s Fulbright appointment focused heavily on teaching and program evaluation, it also opened new avenues for scientific collaboration that align with his long-standing research interests in drug discovery.
One of the most promising outcomes of the Fulbright appointment was a new research partnership with KSIU researchers focused on the largely unexplored biodiversity of the Red Sea. Their work uses genome-mining approaches to identify potentially bioactive molecules from marine organisms, an area that remains relatively unexplored.
“The Red Sea remains a largely underexplored resource for the discovery of structurally and biologically unique natural products,” Dr. Kurosu said.
The collaboration combines KSIU’s expertise in genomic analysis with Dr. Kurosu’s background in synthetic chemistry and bioassay development, complementing his broader drug-discovery research program at UT Health Sciences, which focuses on developing innovative treatments for cancer and infectious diseases. Together, researchers hope to identify novel compounds that could serve as starting points for future therapeutic development, expanding the pipeline of molecules that may one day contribute to new therapies.
“The perspectives and experiences gained abroad should enrich our own teaching, research and international outlook when we return to the United States.”
Michio Kurosu, PhD
One collaborative research article was accepted for publication this month, a tangible outcome of the research relationships built during the Fulbright appointment. The study grew directly out of the scientific exchange between Dr. Kurosu and his KSIU colleagues, and it lays the groundwork for additional joint publications, with the long-term goal of building a sustainable research partnership that continues well beyond his Fulbright appointment.
“I believe that sustained efforts through this program will lead to the identification of promising lead compounds and provide new opportunities for future drug discovery and development,” Dr. Kurosu said.
Improving Through Exchange
The Fulbright Program was created to strengthen relationships among nations through educational and cultural exchange, and the experience reinforced for Dr. Kurosu that international collaboration is most effective when learning flows in both directions. While he shared his expertise with students and faculty in Egypt, he also gained new perspectives on education, research and scientific problem-solving.
“The knowledge and experience that we bring should be shared in ways that strengthen education, research capacity and scientific development in the host institution and country,” he said. “At the same time, the perspectives and experiences gained abroad should enrich our own teaching, research and international outlook when we return to the United States.”
A Renewed Sense of Purpose
The determination of researchers and students at KSIU, despite having far fewer opportunities, limited economic resources and less infrastructure compared to their counterparts in the United States — yet still working tirelessly to solve important research questions — inspired Dr. Kurosu with a new sense of purpose.
“This experience made me more deeply appreciate the rich academic and research environment available to us and reminded me of the fundamental motivation that led me to become a scientist: the desire to challenge unanswered questions and discover something new,” he said.
As he returns to his research and teaching responsibilities at UT Health Sciences, Dr. Kurosu said he brings back not only new scientific collaborations and educational partnerships, but also a stronger commitment to using those opportunities to advance research, support students and contribute to scientific discovery both at home and abroad.